ARNI

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 10/24/2016
Contact Info
  • 20550 SW 115th Ave
  • Tualatin, OR 97062

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001195116
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. Not Available
Employees 4 a/o Mar 31, 2016
Company Officers/Contacts
Alexander Zukiwski CEO, Chief Med. Officer
Lester Szymanik Director, Fin.
Company Directors
Not Available
Company Notes
  • Formerly=Laurier International, Inc. until 7-2008
Service Providers
Accounting/Auditing Firm
Crowe Horwath, LLP
488 Madison Avenue
3rd Floor
New York, NY, 10022
United States

Legal Counsel
Fredrikson & Byron, P.A.
200 S. Sixth St.
Suite 4000
Minneapolis, MN, 55402
United States

Investor Relations Firm
Not Available
ARNI Security Details
Share Structure
Market Value1 $13,719,230 a/o Dec 02, 2016
Authorized Shares 500,000,000 a/o Sep 30, 2016
Outstanding Shares 49,349,749 a/o Nov 09, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 14,000,000 a/o Sep 30, 2016
Par Value Not Available
Shareholders
Shareholders of Record 250 a/o Sep 30, 2016
Short Selling Data
Short Interest 8,242 (27.59%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security